-
- Target Alle CD31 (PECAM1) Antikörper anzeigen
- CD31 (PECAM1) (Platelet/endothelial Cell Adhesion Molecule (PECAM1))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD31 Antikörper ist konjugiert mit PE
-
Applikation
- Flow Cytometry (FACS)
- Kreuzreaktivität
- Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops), Pavian, Cynomolgus, Rhesusaffen, Green Monkey (Chlorocebus sabaeus)
- Aufreinigung
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
- Klon
- WM59
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product PECAM1 Primärantikörper
-
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) (AA 601-680) antibody
PECAM1 Reaktivität: Human, Maus, Ratte, Kaninchen, Schwein, Hund FACS, WB, ELISA, IHC (p), IHC (fro), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) (C-Term) antibodyPECAM1 Reaktivität: Human, Maus, Ratte, Hund, Affe WB, IHC Wirt: Ziege Polyclonal unconjugated
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) antibodyPECAM1 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) (AA 28-382) antibodyPECAM1 Reaktivität: Human, Ratte FACS, WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) (AA 681-738) antibodyPECAM1 Reaktivität: Human, Maus, Ratte, Kaninchen, Schwein, Rind (Kuh) FACS, WB, ELISA, IHC (p), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) (AA 28-315) antibodyPECAM1 Reaktivität: Human FACS, WB, IHC, IF, ELISA Wirt: Maus Monoclonal 9E6E12 unconjugated
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) (AA 29-738) antibodyPECAM1 Reaktivität: Human WB, ELISA, IP, IHC (p) Wirt: Maus Monoclonal 1D2-1A5 unconjugated
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) antibodyPECAM1 Reaktivität: Human, Kaninchen, Cynomolgus FACS, WB, IHC, IF, StM Wirt: Maus Monoclonal JC-70A unconjugated
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) antibodyPECAM1 Reaktivität: Human, Ratte FACS, WB, IHC, IF, StM Wirt: Maus Monoclonal C31-3 unconjugated
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) (AA 625-738) antibodyPECAM1 Reaktivität: Human FACS, IHC, IF, StM Wirt: Maus Monoclonal PECAM1-3527 unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Protect from prolonged exposure to light. Do not freeze.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
- Target
- CD31 (PECAM1) (Platelet/endothelial Cell Adhesion Molecule (PECAM1))
- Andere Bezeichnung
- CD31 (PECAM1 Produkte)
- Synonyme
- CD31 antikoerper, CD31/EndoCAM antikoerper, GPIIA' antikoerper, PECA1 antikoerper, PECAM-1 antikoerper, endoCAM antikoerper, C85791 antikoerper, Cd31 antikoerper, Pecam antikoerper, platelet/endothelial cell adhesion molecule 1 antikoerper, platelet and endothelial cell adhesion molecule 1 antikoerper, pecam1 antikoerper, PECAM1 antikoerper, Pecam1 antikoerper
- Hintergrund
- CD31 is a 130-140 kD type I transmembrane glycoprotein also known as platelet endothelial cell adhesion molecule-1 (PECAM-1) or Endocam. It is expressed on monocytes, platelets, granulocytes, endothelial cells and lymphocyte subsets. CD31 has been reported to bind CD38 and be involved in wound healing, angiogenesis, and cellular migration in an inflammatory situation.
- Pathways
- Regulation of Actin Filament Polymerization
-
Sie sind hier:
